Medicines, 2018
Shortlist up to four to read them side by side.
1,426 medicine recalls FDA’s Enforcement Report published in 2018, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 5, 2026.
1,426of 1,426 medicine recallsshown with your filters
The list
- Medicine recall Altera Handset Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Cayston 75 mg Inh Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Repatha 140 mg/mL Sureclick AI 2-pk Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Enbrel PFS 50 mg/mL Inj #4 Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Botox 100 Units Vial Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Prolia 60 mg/1 mL PF syringe Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Kitabis Pak 300 mg/5 mL Soln PARI #56 Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Orkambi 200 mg/125 mg Tablets #112 Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Orkambi 100 mg/125 mg Tablets #112 Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Bethkis 300 mg/4 mL Ampule #56 Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Pulmozyme 1 mg/mL Inh Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Azithromycin 250 mg tablet #18 TEV Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Creon DR 24,000 Units Capsule #250 Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall MVW Complete Softgels Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Sodium Chloride 3% Inh. 4 mL NEP #30 Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Xolair 150 mg SDV Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Vosevi 400/100/100 mg Tablets #28 Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Dupixent 300 mg/2 mL PFS #2 w/ NS Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Boost VHC Oral Liquid VAN #27 Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Stelara 90 mg/MI PFS Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Cimzia 200 mg/mL PFS Kit #2 Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Praluent 75 mg Pen Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Copaxone 40 mg Injection Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Copaxone 20 mg Injection PFS Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Tecfidera 240 mg capsule Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Pomalyst 3 mg capsule Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Xtandi 40 mg capsule Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Promacta 50 mg tablet Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Revlimid 10 mg oral cap Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Revlimid 15 mg oral cap Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Revlimid 20 mg oral cap Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Revlimid 5 mg oral cap Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Revlimid 25 mg oral cap Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Avonex 30 mcg/0.5 mL PFS Kit Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Ibrance 125 mg cap Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Glatiramer Acetate 40 mg/mL Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Xalkori 250 mg cap Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Temozolomide 20 mg Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Temozolomide 250 mg Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Gleevec 100 mg tablet Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Sprycel 80 mg tablet Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Sprycel 100 mg tablet Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Cyclophosphamide 50 mg cap Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Dexamethasone 4 mg tablet Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Sutent 37.5 mg capsules x28 Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Sutent 50 mg capsules x28 Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Imatinib Mesylate Tablet 400 mg Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
- Medicine recall Capecitabine 150 mg Tablet Lack of Processing Controls. Class IIFDA’s classMay 16, 2018in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 16, 2018ClassClass IIStatusTerminatedWhereArkansas, Florida, Illinois, Louisiana and Mississippi
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.